CastleKnight Management LP Sells 23,600 Shares of Helen of Troy Limited $HELE

Posted by Stanley Muller on Jun 18th, 2026

CastleKnight Management LP decreased its holdings in shares of Helen of Troy Limited (NASDAQ:HELE – Free Report) by 4.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 468,300 shares of the company’s stock after selling 23,600 shares during the period. CastleKnight Management LP owned about 2.03% of Helen of Troy worth $9,951,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently modified their holdings of the company. Envestnet Asset Management Inc. grew its position in shares of Helen of Troy by 42.4% during the 3rd quarter. Envestnet Asset Management Inc. now owns 195,657 shares of the company’s stock valued at $4,931,000 after acquiring an additional 58,214 shares during the period. Counterpoint Mutual Funds LLC lifted its stake in shares of Helen of Troy by 882.6% during the 3rd quarter. Counterpoint Mutual Funds LLC now owns 125,416 shares of the company’s stock valued at $3,160,000 after buying an additional 112,652 shares in the last quarter. Invenomic Capital Management LP lifted its stake in shares of Helen of Troy by 68.8% during the 3rd quarter. Invenomic Capital Management LP now owns 554,985 shares of the company’s stock valued at $13,986,000 after buying an additional 226,263 shares in the last quarter. Seven Six Capital Management LLC purchased a new position in shares of Helen of Troy during the 3rd quarter valued at $1,378,000. Finally, Prescott Group Capital Management L.L.C. purchased a new position in shares of Helen of Troy during the 4th quarter valued at $2,344,000.

Helen of Troy News Roundup

Here are the key news stories impacting Helen of Troy this week:

Positive Sentiment: Helen of Troy was highlighted by Zacks as one of four cosmetics stocks benefiting from favorable industry trends, including stronger skincare demand, product innovation, and expanding digital channels. Article Title
Neutral Sentiment: Several law firms issued investor reminders and lead-plaintiff notices related to the already-filed class action against Helen of Troy, which mainly reinforces the lawsuit timeline rather than adding new business developments. Article Title
Negative Sentiment: The class-action filings allege misleading statements about operational health and distribution-center failures, creating a legal overhang that may keep pressure on HELE shares until the claims are resolved. Article Title

Helen of Troy Stock Down 7.4%

Shares of HELE stock opened at $26.47 on Thursday. The stock has a market cap of $615.69 million, a P/E ratio of -0.68 and a beta of 1.34. Helen of Troy Limited has a 52 week low of $13.85 and a 52 week high of $33.73. The company has a quick ratio of 0.81, a current ratio of 1.71 and a debt-to-equity ratio of 0.95. The company’s fifty day simple moving average is $23.60 and its two-hundred day simple moving average is $20.11.

Helen of Troy (NASDAQ:HELE – Get Free Report) last announced its quarterly earnings results on Thursday, April 23rd. The company reported $0.83 EPS for the quarter, topping the consensus estimate of $0.74 by $0.09. The business had revenue of $470.03 million for the quarter, compared to analysts’ expectations of $450.38 million. Helen of Troy had a negative net margin of 50.33% and a positive return on equity of 7.00%. The business’s quarterly revenue was down 3.3% compared to the same quarter last year. During the same quarter in the previous year, the company earned $2.33 EPS. Helen of Troy has set its FY 2027 guidance at 3.250-3.750 EPS. Analysts predict that Helen of Troy Limited will post 2.81 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research analysts recently weighed in on HELE shares. Zacks Research upgraded shares of Helen of Troy from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, May 5th. Canaccord Genuity Group lifted their target price on shares of Helen of Troy from $18.00 to $23.00 and gave the company a “hold” rating in a research note on Friday, April 24th. UBS Group lifted their target price on shares of Helen of Troy from $16.00 to $25.00 and gave the company a “neutral” rating in a research note on Friday, April 24th. Weiss Ratings restated a “sell (d-)” rating on shares of Helen of Troy in a research note on Friday, March 27th. Finally, Wall Street Zen cut shares of Helen of Troy from a “buy” rating to a “hold” rating in a research note on Saturday, May 23rd. Two analysts have rated the stock with a Strong Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $24.00.

Read Our Latest Stock Analysis on Helen of Troy

About Helen of Troy

(Free Report)

Helen of Troy Limited is a global consumer products company that designs, sources and markets a diversified portfolio of household, health and beauty brands. Headquartered in El Paso, Texas, the company operates through three principal segments—Health & Home, Housewares and Beauty—offering products under well-known names including OXO, Vicks, Braun, Honeywell Home, PUR and Hot Tools. Helen of Troy distributes its products through a combination of mass, specialty and e-commerce channels to consumers, retailers and distributors worldwide.

The Housewares segment features kitchen tools, gadgets and organizational solutions marketed primarily under the OXO brand, recognized for its ergonomic “Good Grips” design.